1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Digestive Diseases Center Pilot Grants is sponsored by Texas Medical Center Digestive Diseases Center (DDC) (Baylor College of Medicine). The DDC is offering seed money for pilot/feasibility projects in GI-related research. The overall theme is “Molecular mechanisms and outcomes of injury, infection, or metabolic dysfunction of the digestive system” with subthemes centering on infection, injury, and metabolism.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
TMC Digestive Disease Center Funding | BCM TMC Digestive Disease Center Funding Texas Medical Center Digestive Diseases Center Pilot/Feasibility Awards The Texas Medical Center Digestive Diseases Center provides support to pilot/feasibility (P/F) projects in the area of GI-related research each year. These funds specifically support projects related to the theme for the DDC.
The overall theme of the DDC is “Molecular mechanisms and outcomes of injury, infection, or metabolic dysfunction of the digestive system” with digestive-disease-related subthemes centering on: Infection (including host-microbe interactions and microbiome) Injury (including tumorigenesis and stem cell response) Metabolism (including diseases associated with obesity and the gut-brain axis) GI is defined as the gastrointestinal tract, liver and pancreas.
Injury is defined as drug, genetic, ischemic, inflammatory, surgical, nutritional, or stress-induced injury to the gastrointestinal tract. Injury also includes gastrointestinal adaptation and stem cells. Proposed projects must fall within one of the above mentioned subthemes.
Awards range between $35,000 to $50,000 for a period of one year. A committee composed of the DDC Internal Advisory Board, plus ad hoc members, evaluates proposals. Anyone interested in applying for a DDC Pilot Feasibility Award is welcome to participate in a virtual Q&A Session on Oct.
16, 2025 at 2 p. m. For more information about this online session, please contact the DDC administrator, Sara Tristan or the DDC coordinator, Dionysia Briscoe .
All faculty members from within the Texas Medical Center Digestive Diseases Center consortium are eligible to apply. This includes Baylor College of Medicine, The University of Texas Health Science Center, and MD Anderson Cancer Center. Faculty members at other institutions are eligible if they submit a grant that collaborates with a faculty member who is also a member of the Digestive Diseases Center.
Trainees also should have a commitment from a senior scientist to sponsor their projects and assurance of future faculty appointment from Section/Dept Head. Trainee applicants for pilot projects are not required to be United States citizens or possess a permanent resident visa. Funding preference will be given to early-stage career faculty.
The purpose of these grants is to help early-career investigators establish an independent research program and to encourage the involvement of established investigators not currently working in the GI area. All persons interested in submitting an application should initially submit a Notice of Intent with a tentative application title, and the name of the PI, any co-PIs, and their affiliations via the online system.
Questions can be directed to DDC administrator, Sara Tristan or the DDC coordinator, Dionysia Briscoe . The online system will be made available Oct. 20, 2025 and Notice of Intent must be received by Nov.
10, 2025. This should include PI information, tentative project title, and a brief description of the study. A notice of intent is required for any interested applicant.
Applicant must adhere to the application instructions and include the required cover sheet when submitting their application. T he completed application (including the Summary Sheet) should be submitted as one PDF file via our online system by 5 p. m.
CST on Jan. 5, 2026 . You will receive a confirmation email once you have submitted your application.
If you do not receive a notification, email DDC administrator, Sara Tristan or the DDC coordinator, Dionysia Briscoe prior to the 5 p. m. CST deadline.
View the online application New Investigator (N) : Investigators without current or past NIH support at the R01 level. K08, K01, and K23 recipients are eligible and are encouraged to apply.
Trainees who are recipients of an NRSA individual award (F32) or are supported by an institutional training grant (T32) are eligible for P/F funds, if they are in their last year of training, have had at least one year of research laboratory experience, and have suitable expertise and independence to design and carry out the planned experiments.
Established Investigator New to Digestive Diseases Research (NTF) : Established Investigators from other areas of biomedical research who intend to use their expertise for digestive diseases research. Established Digestive Disease Investigator (E) : Established digestive disease researcher who previously had R01 level funding but does not currently have R01 or R01-level equivalent funding as a PI or Multi PI.
Eligible investigators could also be in the final/no cost extension year of R01 or R01-level equivalent funding. Click to View 2025/2026 Program announcement
According to the current listing, eligibility includes: All faculty members from within the Texas Medical Center Digestive Diseases Center consortium (Baylor College of Medicine, The University of Texas Health Science Center, and MD Anderson Cancer Center) are eligible. Confirm the full requirements in the official notice before applying.
The current listing shows up to $50,000 each (direct costs only). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Digestive Diseases Center Pilot Grants is funded by Texas Medical Center Digestive Diseases Center (DDC) (Baylor College of Medicine). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Texas. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.
Read article